CH
AMPE

CVI Holdings’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

CVI Holdings’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-341
Closed -$348K – 64
2018
Q1 		$348K Buy
+341
New +$285K 0.47% 24

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

CVI Holdings's AMPE Position: Q1 2022 in Review

CVI Holdings sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022, closing a stake of 17,240 shares — an estimated $2.95M sold.

CVI Holdings first reported a position in AMPE in Q4 2019 and held it in 2 quarters. The position peaked at $2.95M in Q4 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • CVI Holdings reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • CVI Holdings sold 17,240 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $2.95M.
  • CVI Holdings first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and held it in 2 quarters.
  • CVI Holdings's Ampio Pharmaceuticals Inc. position peaked at $2.95M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on CVI Holdings's 13F filing for Q1 2022, filed 16 May 2022.